Sectors
HUMA
Humacyte, Inc.
0.60
2 x 0.45
2 x 0.76
bid
ask
-
0.05
7.49%
2 @ 08:53 AM
0.61 +0.01 (0.98%)
| Ytd | -37.42% | |
| 1y | -61.20% |
0.58
day range
0.65
0.53
52 week range
2.55
| Open | 0.65 | Prev Close | 0.65 | Low | 0.58 | High | 0.65 | Mkt Cap | 167.07M |
| Vol | 13.52M | Avg Vol | 10.95M | EPS | -0.52 | P/E | N/A | Forward P/E | -5.41 |
| Beta | 2.53 | Short Ratio | 6.37 | Inst. Own | 30.01% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-12 | 50-d Avg | 0.68 | 200-d Avg | 0.95 | 1yr Est | 13.71 |
| Income Statement | |||
| Total Revenue | 406.00K | ||
| Revenues (USD) | 406.00K | ||
| Cost of Revenue | 1.23M | ||
| Gross Profit | -825.00K | ||
| Operating Expenses | 26.17M | ||
| Research and Development Expense | 18.14M | ||
| Selling, General and Administrative Expense | 8.03M | ||
| Operating Income | -27.00M | ||
| Interest Expense | 2.32M | ||
| Net Income | -36.80M | ||
| Net Income Common Stock | -36.80M | ||
| Net Income Common Stock (USD) | -36.80M | ||
| Consolidated Income | -36.80M | ||
| Earnings per Basic Share | -0.16 | ||
| Earnings per Basic Share (USD) | -0.16 | ||
| Earnings per Diluted Share | -0.16 | ||
| Earning Before Interest & Taxes (EBIT) | -34.48M | ||
| Earning Before Interest & Taxes (USD) | -34.48M | ||
| Weighted Average Shares | 234.18M | ||
| Weighted Average Shares Diluted | 234.18M | ||
| Balance Sheet | |||
| Cash and Equivalents | 80.11M | ||
| Cash and Equivalents (USD) | 80.11M | ||
| Trade and Non-Trade Receivables | 330.00K | ||
| Current Assets | 92.79M | ||
| Property, Plant & Equipment Net | 44.42M | ||
| Total Assets | 138.09M | ||
| Debt Current | 1.52M | ||
| Total Debt | 66.18M | ||
| Current Liabilities | 14.95M | ||
| Debt Non-Current | 64.66M | ||
| Total Liabilities | 106.83M | ||
| Accumulated Retained Earnings (Deficit) | -781.27M | ||
| Shareholders Equity | 31.26M | ||
| Shareholders Equity (USD) | 31.26M | ||
| Assets Non-Current | 45.30M | ||
| Total Debt (USD) | 66.18M | ||
| Inventory | 6.99M | ||
| Liabilities Non-Current | 91.88M | ||
| Trade and Non-Trade Payables | 4.16M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 1.79M | ||
| Net Cash Flow from Financing | 53.53M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 31.36M | ||
| Capital Expenditure | -104.00K | ||
| Issuance (Purchase) of Equity Shares | 53.70M | ||
| Issuance (Repayment) of Debt Securities | -174.00K | ||
| Net Cash Flow from Investing | -104.00K | ||
| Net Cash Flow from Operations | -22.06M | ||
| Share Based Compensation | 2.61M | ||